AHA 2017

Empagliflozin Cuts CVD Risk in Patients With Type 2 Diabetes, PAD

By November 15, 2017

At study start, 21% of the more than 7,000 EMPA-REG OUTCOME trial participants had existing peripheral artery disease.

Does Noninvasive Testing Improve Outcomes in Patients With Acute Chest Pain?

November 15, 2017

Noninvasive testing with CCTA or stress testing also leads to more radiation exposure, greater cost

Evolocumab Found to Benefit Patients With PAD, History of MI

By November 15, 2017

Analysis showed that patients with more recent heart attacks experienced substantial risk reductions.

Methamphetamine Heart Failure May Present New Phenotype

November 15, 2017

"Clinicians are seeing more heart failure with meth use, suggesting heart failure due to methamphetamine use could be a new epidemic," said lead author, Marin Nishimura, MD, in a statement.

Canakinumab Cuts Major Adverse CV Events Risk in Subgroup

By November 14, 2017

This analysis indicates that on-treatment hsCRP testing may offer a quick and reliable way to identify the patients most likely to achieve the greatest benefits from long-term canakinumab treatment.

AHA/ACC: New Guidelines Redefine 'High Blood Pressure'

November 14, 2017

In 2013 the U.S. government asked the AHA and ACC to draft new guidelines for blood pressure management.

CCBs May Improve Outcomes in Patients With Hypertrophic Cardiomyopathy

By November 14, 2017

The combined endpoint evaluated was the time to event of atrial fibrillation, ventricular arrhythmia, heart failure, myectomy, ICD implant, or sudden cardiac arrest.

Does Use of Apixaban With Cardiac P-gp Inhibitors Up Bleeding Risk?

By November 14, 2017

Apixaban is a substrate of P-glycoprotein and P-glycoprotein inhibition increases drug exposure.

Antidiabetic Agents Compared in Patients With Diabetes and Heart Failure

By November 14, 2017

Data from the Duke University Health System (DUHS) electronic health records were used to identify patients with both diabetes and heart failure.

Is One Statin More Likely to Increase Myopathy Risk Over Another?

By November 14, 2017

Myopathy is frequently cited as a reason for statin therapy cessation.

Direct Oral Anticoagulant Use Increasing in Dialysis Patients With AFib

By November 14, 2017

End-stage renal disease patients on dialysis with atrial fibrillation are at high risk for thrombotic complications.

First Nationwide Study Examines Cardiac Mortality in Young With Diabetes

November 14, 2017

All individuals in Denmark aged 1-35 in 2000-09 and 36-49 in 2007-09 were included in the study.

More Coffee: Each Additional Cup May Help Reduce HF, Stroke Risk

November 14, 2017

The researchers used random forest machine-learning methods to identify risk factors associated with cardiovascular diseases based on data from the Framingham Heart Study.

Does Sodium Bicarbonate Benefit Patients With Impaired Kidney Function Undergoing Angiography?

November 14, 2017

A total of 5,177 patients at high risk for renal complications were randomized and scheduled for angiography to receive intravenous sodium bicarbonate or sodium chloride and 5 days of oral acetylcysteine or placebo.

Cardiac Troponin I Concentration May ID Patients at Low Risk of MI, Cardiac Death

November 13, 2017

The primary outcome of myocardial infarction or cardiac death at 30 days occurred in 12.4% of the 22,457 patients included in the meta-analysis.